Industry experts share their expectations and wish-list from Budget 2015. FM Arun Jaitley's first Union Budget for heralding the good days We... ...http://www.financialexpress.com/article/pharma/management-pharma/budget-2015-awaiting-achche-din/47239/
BS Biotech is expecting Rs 425 crore sales revenue from Kesh King in 2014-15. Talks for selling Kesh King, the biggest brand of the Himachal... ...http://www.afaqs.com/news/story/43382_Talks-for-Kesh-King-hair-oil-fall-through
It has applied for Para IV approvals with USFDA for fingolimod (used to treat multiple sclerosis) and cabazitaxel (used for treating patients with... ...http://www.business-standard.com/article/companies/natco-files-anda-applications-for-cancer-and-multiple-sclerosis-drugs-in-us-115021000755_1.html
at firms too spent anything between Rs 250-750 crore on R&D in FY14 BS Reporter | Ahmedabad February 8, 2015 Last Updated at 20:59 IST Over the... ...http://www.business-standard.com/article/companies/pharma-cos-increase-focus-on-research-and-development-report-115020800696_1.html
Published on Wed, Feb 04,2015|18:47, Updated at Wed, Feb 04 at 18:47Source : Moneycontrol.com By: Shuchi Ray- Director & Nimisha... ...http://www.moneycontrol.com/news/features/location-savings-does-it-call-for-a-tp-adjustment_1292517.html
Ultimate Job Portal for Healthcare...